facebook linked in twitter youtube instagram

The First 100 Days Updates & Resources

Click here to access insights and external resources collected by Nelson Mullins on the first 100 days of the new presidential administration and Congress. These articles and fact sheets are non-partisan in nature and address the impact of each on various industries and client sectors.

COVID-19 Resources

Click here to access our extensive COVID-19 resources that address a wide variety of topics in general and by industry.

The LatestView All

Nelson Mullins Lawyers Named to Law360 Editorial Advisory Boards

April 8, 2021

Nelson Mullins Lawyers Named to Law360 Editorial Advisory Boards
close

Press Releases

April 21, 2021

Life Sciences Regulatory Attorney Christopher Hanson Joins Nelson Mullins in D.C.

WASHINGTON, D.C. – Life sciences regulatory attorney Christopher J. Hanson has joined Nelson Mullins Riley & Scarborough LLP in its Washington, D.C. office as a partner. He joins from Covington & Burling LLP, where he was a special counsel. 

Hanson assists clients in tackling their most sophisticated and high-stakes regulatory issues involving medical devices, in vitro diagnostics, clinical laboratories, human and animal drugs, cosmetics, and radiation-emitting electronic products. He represents product manufacturers as well as industry groups seeking input into regulatory rulemakings and policies and drafting life sciences legislation. He also has experience preparing regulatory product submissions, responding to agency enforcement actions, and conducting global internal investigations and audits.

“Christopher has significant experience working with the U.S. Food and Drug Administration, the Centers for Medicare & Medicaid Services, and the Federal Trade Commission,” said Jennifer Mallory, who leads the FDA Regulatory Compliance & Litigation Group. “He brings additional depth to our services, especially those offered to our clients in the medical device, in vitro diagnostics, and clinical laboratory spaces. We are delighted to welcome Christopher to our group that shares Christopher’s commitment to crafting creative and practical solutions for clients regulated by FDA, CMS, and the FTC.”

Hanson earned his J.D. from Northwestern University School of Law, a Master of Divinity from Harvard University, and a B.A. from Yale University.

The Nelson Mullins FDA Compliance and Litigation Team represents FDA-regulated industries, advising general counsels, executives, clinical research professionals, physicians, and other healthcare providers. The team includes lawyers, pharmacists, and nurse consultants who have worked in the public and private sectors and developed an understanding of the real issues that clients face when navigating the FDA regulatory scheme.

Established in 1897, Nelson Mullins is an AmLaw100 firm with more than 800 attorneys and government relations professionals with offices in 11 states and Washington, DC. For more information on the firm, go to www.nelsonmullins.com.



What's New
Idea Exchange
Top